Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Corporate Presentation services provided by Jsc Olainfarm

Jsc Olainfarm
Corporate Presentation
Full Screen View

PDF Upload Sep, 2024

Olpha will already be offering four new medicines on EU markets this year

09 Jul 2024

// PRESS RELEASE

Olainfarm transforms into Olpha, aiming to become Europe’s TOP 10 pharmaceutical

19 Jun 2024

// PRESS RELEASE

Six young chemistry and biology teachers in Latvia are awarded scholarships of 18 000 euros

03 May 2024

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Olpha

Contact Supplier

PackExpo

Not Confirmed

Book a meeting now

envelop Contact Supplier

Xls

CATEGORY PAGE

Jsc Olainfarm

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, FDF Product List 2024, GMP Certificate 2023

Product List 2024
Corporate Presentation
FDF Product List 2024
GMP Certificate 2023

VIDEO(s)

Corporate Video, Conference - Health, Safety, Pharmacy, Olainfarm 50, Taking Care of Your Health for Already 50 Years, Presentation on Nasdaq Tower

Corporate Video
Conference - Health, Safety, Pharmacy
Olainfarm 50
Taking Care of Your Health for Already 50 Years
Presentation on Nasdaq Tower

DIGITAL CONTENT

9 CORPORATE CONTENT #SupplierSpotlight, 91 NEWS #PharmaBuzz

9 CORPORATE CONTENT #SupplierSpotlight
91 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

11 All APIs, 4 USDMF, 2 CEP/COS, 2 JDMF, 2 KDMF, 8 NDC API, 9 Listed APIs

11 All APIs
4 USDMF
2 CEP/COS
2 JDMF
2 KDMF
8 NDC API
9 Listed APIs

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

20 ALL Intermediates

20 ALL Intermediates

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers, 33 Listed Dossiers

33 FDF Dossiers
33 Listed Dossiers

KEY PRODUCTS

1,3-Dimethyladamantane, 3-Quinuclidinone Hydrochloride, Chlorobutanol Hemihydrate, Memantine Hydrochloride, Rimantadine Hydrochloride

1,3-Dimethyladamantane
3-Quinuclidinone Hydrochloride
Chlorobutanol Hemihydrate
Memantine Hydrochloride
Rimantadine Hydrochloride

SERVICES

Clinical Trials, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

Clinical Trials
- 1 Clinical Development / Phase IIb-IV
API Manufacturing
- 1 Fine Chemical / Intermediate
Drug Product Manufacturing
- 1 Tablet
- 1 Capsule
API & Drug Product Development
- 2 API Development
- 2 Formulation Development

INSPECTIONS & REGISTRATIONS

3 FDA, 6 EDQM, 1 GDUFA

3 FDA
6 EDQM
1 GDUFA

PC100669

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?